摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-苄基-1,4-二氮杂环庚-5-酮 | 55186-89-5

中文名称
1-苄基-1,4-二氮杂环庚-5-酮
中文别名
1-苄基-1,4-二氮杂-5-环庚酮;1-苄基-1,4-二氮杂环庚烷-5-酮;N-苄基高哌嗪-5-酮
英文名称
1-benzyl-1,4-diazepan-5-one
英文别名
1-benzyl-[1,4]diazepan-5-one;1-Benzyl-hexahydro-[1,4]diazepin-5-on;hexahydro-1-(phenylmethyl)-5H-1,4-diazepin-5-one;1-benzylhexahydro-(5H)-1,4-diazepine-5-one;1-benzylhexahydro-1H-1,4-diazepin-5-one;1-benzyl-(1,4)-diazepan-5-one
1-苄基-1,4-二氮杂环庚-5-酮化学式
CAS
55186-89-5
化学式
C12H16N2O
mdl
MFCD00225259
分子量
204.272
InChiKey
DKNOPZCYIDBMNY-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 熔点:
    115-117°
  • 沸点:
    379.8±35.0 °C(Predicted)
  • 密度:
    1.097±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    0.8
  • 重原子数:
    15
  • 可旋转键数:
    2
  • 环数:
    2.0
  • sp3杂化的碳原子比例:
    0.416
  • 拓扑面积:
    32.3
  • 氢给体数:
    1
  • 氢受体数:
    2

安全信息

  • 海关编码:
    2933990090
  • 危险性防范说明:
    P261,P280,P305+P351+P338
  • 危险性描述:
    H302+H312+H332,H315,H319,H335

SDS

SDS:54b074bd3e5e28b74475283895a090b1
查看
Material Safety Data Sheet

Section 1. Identification of the substance
Product Name: 1-Benzyl-1,4-diazepan-5-one
Synonyms:

Section 2. Hazards identification
Harmful by inhalation, in contact with skin, and if swallowed.

Section 3. Composition/information on ingredients.
Ingredient name: 1-Benzyl-1,4-diazepan-5-one
CAS number: 55186-89-5

Section 4. First aid measures
Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing
contaminated clothing and shoes. If irritation persists, seek medical attention.
Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate
flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical
attention.
Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention.
Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention.

Section 5. Fire fighting measures
In the event of a fire involving this material, alone or in combination with other materials, use dry
powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus
should be worn.

Section 6. Accidental release measures
Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national
standards.
Respiratory precaution: Wear approved mask/respirator
Hand precaution: Wear suitable gloves/gauntlets
Skin protection: Wear suitable protective clothing
Eye protection: Wear suitable eye protection
Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container
for disposal. See section 12.
Environmental precautions: Do not allow material to enter drains or water courses.

Section 7. Handling and storage
Handling: This product should be handled only by, or under the close supervision of, those properly qualified
in the handling and use of potentially hazardous chemicals, who should take into account the fire,
health and chemical hazard data given on this sheet.
Storage: Store in closed vessels.

Section 8. Exposure Controls / Personal protection
Engineering Controls: Use only in a chemical fume hood.
Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles.
General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse.

Section 9. Physical and chemical properties
Appearance: Not specified
Boiling point: No data
Melting point: No data
Flash point: No data
Density: No data
Molecular formula: C12H16N2O
Molecular weight: 204.3

Section 10. Stability and reactivity
Conditions to avoid: Heat, flames and sparks.
Materials to avoid: Oxidizing agents.
Possible hazardous combustion products: Carbon monoxide, nitrogen oxides.

Section 11. Toxicological information
No data.

Section 12. Ecological information
No data.

Section 13. Disposal consideration
Arrange disposal as special waste, by licensed disposal company, in consultation with local waste
disposal authority, in accordance with national and regional regulations.

Section 14. Transportation information
Non-harzardous for air and ground transportation.

Section 15. Regulatory information
No chemicals in this material are subject to the reporting requirements of SARA Title III, Section
302, or have known CAS numbers that exceed the threshold reporting levels established by SARA
Title III, Section 313.


SECTION 16 - ADDITIONAL INFORMATION
N/A

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
    N-苄基哌啶酮 1-benzyl-4-piperidone 3612-20-2 C12H15NO 189.257
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量
    1-苄基高哌嗪 1-benzyl-[1,4]diazepane 4410-12-2 C12H18N2 190.288
    —— 1-benzyl-4-methyl-1,4-diazepane 59039-76-8 C13H20N2 204.315
    —— 1-Benzyl-1,4-diazepane-5-thione —— C12H16N2S 220.34

反应信息

  • 作为反应物:
    描述:
    1-苄基-1,4-二氮杂环庚-5-酮 在 lithium aluminium deuteride 、 palladium diacetate 、 三乙酰氧基硼氢化钠caesium carbonateR-(+)-1,1'-联萘-2,2'-双二苯膦 作用下, 以 四氢呋喃1,4-二氧六环二氯甲烷 为溶剂, 20.0~100.0 ℃ 、8.0 MPa 条件下, 反应 216.0h, 生成 6-{5,5-dideutero-4-[1-(propan-2-yl)piperidin-4-yl]-1,4-diazepan-1-yl}-N-(pyridin-4-yl)pyridine-2-carboxamide
    参考文献:
    名称:
    CXCR4 Receptor Antagonists
    摘要:
    披露了一些对CXCR4受体具有拮抗作用的化合物。
    公开号:
    US20130289020A1
  • 作为产物:
    描述:
    N-苄基哌啶酮 在 sodium azide 、 硫酸 作用下, 生成 1-苄基-1,4-二氮杂环庚-5-酮
    参考文献:
    名称:
    New synthesis of (±)-2-piperazinecarboxylic acid.
    摘要:
    (±)-2-哌嗪甲酸的制备是先将N-羰基乙氧基-4-哌啶酮通过施密特重排反应,随后对乳胺进行溴化;接着在单溴乳胺中间体上进行法维斯克重排反应,得到预期产品。
    DOI:
    10.1016/s0040-4039(00)74356-5
点击查看最新优质反应信息

文献信息

  • Novel diazepan derivatives
    申请人:Aebi Johannes
    公开号:US20070249589A1
    公开(公告)日:2007-10-25
    The invention is concerned with novel diazepan derivatives of formula (I) wherein A, X, R 3 , R 4 , R 5 , R 6 , R 8 , R 9 , R 10 , R 11 , R 12 , R 13 , m and n are as defined in the description and in the claims, as well as physiologically acceptable salts thereof. These compounds are antagonists of CCR-2 receptor, CCR-5 receptor and/or CCR-3 receptor and can be used as medicaments.
    这项发明涉及式(I)的新型二氮杂环己烷衍生物,其中A、X、R3、R4、R5、R6、R8、R9、R10、R11、R12、R13、m和n的定义如描述和索赔中所述,以及其生理上可接受的盐。这些化合物是CCR-2受体、CCR-5受体和/或CCR-3受体的拮抗剂,可用作药物。
  • [EN] CXCR4 RECEPTOR ANTAGONISTS<br/>[FR] ANTAGONISTES DU RÉCEPTEUR CXCR4
    申请人:PROXIMAGEN LTD
    公开号:WO2012049277A1
    公开(公告)日:2012-04-19
    The compounds of formula (I) are antagonists of the CXCR4 receptor Wherein R1 , X, Y and R2 are as defined in the claims.
    式(I)的化合物是CXCR4受体的拮抗剂,其中R1、X、Y和R2如权利要求中所定义。
  • Monocyclic or bicyclic carbocycles and heterocycles as factor Xa inhibitors
    申请人:——
    公开号:US20020183324A1
    公开(公告)日:2002-12-05
    The present application describes monocyclic or bicyclic carbocycles and heterocycles and derivatives thereof of Formula I: 1 or pharmaceutically acceptable salt forms thereof, which are useful as inhibitors of factor Xa.
    本申请描述了单环或双环碳环和杂环以及其衍生物的化合物I的公式,或其药用可接受的盐形式,这些化合物对于Xa因子的抑制剂具有用处。
  • Polycyclic pyrazines as potassium ion channel modulators
    申请人:Wang Xiaodong
    公开号:US20050239800A1
    公开(公告)日:2005-10-27
    The present invention provides a genus of polycyclic pyrazines that are useful as modulators of potassium ion channels. The modulators of the invention are of use in both therapeutic and diagnostic methods.
    本发明提供了一类多环吡嗪,可作为钾离子通道调节剂。该发明的调节剂可用于治疗和诊断方法。
  • [EN] POLYCYCLIC PYRIMIDINES AS POTASSIUM ION CHANNEL MODULATORS<br/>[FR] PYRIMIDINES POLYCYCLIQUES UTILISES EN TANT QUE MODULATEURS DU CANAL IONIQUE DU POTASSIUM
    申请人:ICAGEN INC
    公开号:WO2005099711A1
    公开(公告)日:2005-10-27
    The present invention provides a genus of polycyclic pyrimidines that are useful as modulators of potassium ion channels. The modulators of the invention are of use in both therapeutic and diagnostic methods.
    本发明提供了一类多环嘧啶,可作为钾离子通道的调节剂。该发明的调节剂在治疗和诊断方法中均有用处。
查看更多

表征谱图

  • 氢谱
    1HNMR
  • 质谱
    MS
  • 碳谱
    13CNMR
  • 红外
    IR
  • 拉曼
    Raman
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
查看更多图谱数据,请前往“摩熵化学”平台
ir
查看更多图谱数据,请前往“摩熵化学”平台
  • 峰位数据
  • 峰位匹配
  • 表征信息
Shift(ppm)
Intensity
查看更多图谱数据,请前往“摩熵化学”平台
Assign
Shift(ppm)
查看更多图谱数据,请前往“摩熵化学”平台
测试频率
样品用量
溶剂
溶剂用量
查看更多图谱数据,请前往“摩熵化学”平台

同类化合物

(βS)-β-氨基-4-(4-羟基苯氧基)-3,5-二碘苯甲丙醇 (S)-(-)-7'-〔4(S)-(苄基)恶唑-2-基]-7-二(3,5-二-叔丁基苯基)膦基-2,2',3,3'-四氢-1,1-螺二氢茚 (S)-盐酸沙丁胺醇 (S)-3-(叔丁基)-4-(2,6-二甲氧基苯基)-2,3-二氢苯并[d][1,3]氧磷杂环戊二烯 (S)-2,2'-双[双(3,5-三氟甲基苯基)膦基]-4,4',6,6'-四甲氧基联苯 (S)-1-[3,5-双(三氟甲基)苯基]-3-[1-(二甲基氨基)-3-甲基丁烷-2-基]硫脲 (R)富马酸托特罗定 (R)-(-)-盐酸尼古地平 (R)-(+)-7-双(3,5-二叔丁基苯基)膦基7''-[((6-甲基吡啶-2-基甲基)氨基]-2,2'',3,3''-四氢-1,1''-螺双茚满 (R)-3-(叔丁基)-4-(2,6-二苯氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (R)-2-[((二苯基膦基)甲基]吡咯烷 (N-(4-甲氧基苯基)-N-甲基-3-(1-哌啶基)丙-2-烯酰胺) (5-溴-2-羟基苯基)-4-氯苯甲酮 (5-溴-2-氯苯基)(4-羟基苯基)甲酮 (5-氧代-3-苯基-2,5-二氢-1,2,3,4-oxatriazol-3-鎓) (4S,5R)-4-甲基-5-苯基-1,2,3-氧代噻唑烷-2,2-二氧化物-3-羧酸叔丁酯 (4-溴苯基)-[2-氟-4-[6-[甲基(丙-2-烯基)氨基]己氧基]苯基]甲酮 (4-丁氧基苯甲基)三苯基溴化磷 (3aR,8aR)-(-)-4,4,8,8-四(3,5-二甲基苯基)四氢-2,2-二甲基-6-苯基-1,3-二氧戊环[4,5-e]二恶唑磷 (2Z)-3-[[(4-氯苯基)氨基]-2-氰基丙烯酸乙酯 (2S,3S,5S)-5-(叔丁氧基甲酰氨基)-2-(N-5-噻唑基-甲氧羰基)氨基-1,6-二苯基-3-羟基己烷 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-双(2,6-二甲氧基苯基)-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2S)-(-)-2-{[[[[3,5-双(氟代甲基)苯基]氨基]硫代甲基]氨基}-N-(二苯基甲基)-N,3,3-三甲基丁酰胺 (2S)-2-[[[[[[((1R,2R)-2-氨基环己基]氨基]硫代甲基]氨基]-N-(二苯甲基)-N,3,3-三甲基丁酰胺 (2-硝基苯基)磷酸三酰胺 (2,6-二氯苯基)乙酰氯 (2,3-二甲氧基-5-甲基苯基)硼酸 (1S,2S,3S,5S)-5-叠氮基-3-(苯基甲氧基)-2-[(苯基甲氧基)甲基]环戊醇 (1-(4-氟苯基)环丙基)甲胺盐酸盐 (1-(3-溴苯基)环丁基)甲胺盐酸盐 (1-(2-氯苯基)环丁基)甲胺盐酸盐 (1-(2-氟苯基)环丙基)甲胺盐酸盐 (-)-去甲基西布曲明 龙胆酸钠 龙胆酸叔丁酯 龙胆酸 龙胆紫 龙胆紫 齐达帕胺 齐诺康唑 齐洛呋胺 齐墩果-12-烯[2,3-c][1,2,5]恶二唑-28-酸苯甲酯 齐培丙醇 齐咪苯 齐仑太尔 黑染料 黄酮,5-氨基-6-羟基-(5CI) 黄酮,6-氨基-3-羟基-(6CI) 黄蜡,合成物 黄草灵钾盐